BridgeMD
New treatment option for Septic Shock
Official title Effects of Intravenous Metabolic Recovery Agent in Elderly Septic Patients on Prognosis and Microcirculation.
ClinicalTrials.gov ID: NCT06723626
What this study is testing
What is Metabolic resuscitation agent?
Metabolic resuscitation agent is an investigational medicine, given as an infusion into a vein, being studied as a potential treatment for septic shock.
Also referred to as Hydrocortisone, vitamin C and vitamin B1.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- This study intends to observe the effect of intravenous hydrocortisone combined with vitamin C and vitamin B1 infusion on the prognosis and sublingual microcirculation in patients with sepsis or septic shock through a prospective randomized controlled study method.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 60 to 85
You may be able to join if
- Age ≥60 and ≤85 years old;
- Diagnosis of sepsis or septic shock;
- Clinical judgment for hydrocortisone treatment;
- Signing Informed Consent.
You likely can't join if
- patients in palliative care;
- uncontrolled malignancy with multiple metastases;
- ineffective surgical intervention for the infectious agent;
- estimated death within 24 hours;
- glucocorticoids used in the last 7 days;
- allergy to hydrocortisone, vitamin c or vitamin B1;
See the full eligibility criteria
- Age ≥60 and ≤85 years old;
- Diagnosis of sepsis or septic shock;
- Clinical judgment for hydrocortisone treatment;
- Signing Informed Consent.
- patients in palliative care;
- uncontrolled malignancy with multiple metastases;
- ineffective surgical intervention for the infectious agent;
- estimated death within 24 hours;
- glucocorticoids used in the last 7 days;
- allergy to hydrocortisone, vitamin c or vitamin B1;
- inability to measure sublingual microcirculation.
The study team makes the final eligibility decision.
Where it's taking place
- Nanjing, Jiangsu, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 60 years to 85 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Nanjing, Jiangsu, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.